Journal
CELL DEATH AND DIFFERENTIATION
Volume 25, Issue 6, Pages 1094-1106Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41418-017-0054-7
Keywords
-
Categories
Funding
- Austrian Science Fund (FWF) [DK W1212]
- FWF-grant [I764-B13]
- Deutsche Forschungsgemeinschaft [CRC 1149, Immunobone Tu220/6]
- Fonds der Stadt Wien fur innovative interdisziplinare Krebsforschung [AP00288OFF]
- ERC-Advanced grant [694883]
- Austrian Science Fund (FWF) [W1212] Funding Source: Austrian Science Fund (FWF)
Ask authors/readers for more resources
Mice deficient in epidermal growth factor receptor (Egfr(-/-) mice) are growth retarded and exhibit severe bone defects that are poorly understood. Here we show that EGFR-deficient mice are osteopenic and display impaired endochondral and intramembranous ossification resulting in irregular mineralization of their bones. This phenotype is recapitulated in mice lacking EGFR exclusively in osteoblasts, but not in mice lacking EGFR in osteoclasts indicating that osteoblasts are responsible for the bone phenotype. Experiments are presented demonstrating that signaling via EGFR stimulates osteoblast proliferation and inhibits their differentiation by suppression of the IGF-1R/mTOR-pathway via ERK1/2-dependent up regulation of IGFBP-3. Osteoblasts from Egfr(-/-) mice show increased levels of IGF-1R and hyperactivation of mTOR-pathway proteins, including enhanced phosphorylation of 4E-BP1 and S6. The same changes are also seen in Egfr(-/-) bones. Importantly, pharmacological inhibition of mTOR with rapamycin decreases osteoblasts differentiation as well as rescues the low bone mass phenotype of Egfr(-/-) fetuses. Our results demonstrate that suppression of the IGF-1R/mTOR-pathway by EGFR/ERK/IGFBP-3 signaling is necessary for balanced osteoblast maturation providing a mechanism for the skeletal phenotype observed in EGFR-deficient mice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available